Expression of human A53T alpha-synuclein in the rat substantia nigra (modelsParkinson's disease)

Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease.

Enhanced by Zemanta

No comments: